Document is current
Any future updates will be listed below
-
Authors
Zhang, Jiaguan
Gao, Zeshou
Yang, Yi
Li, Zhenhao
Wu, Binjie
Fan, Chunxin
Zheng, Yuyan
Yang, Ruohan
Zhang, Fangrong
Lin, Xiaohuang
Zheng, Daoshan https://orcid.org/0000-0001-8961-5578
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (2022J01195, 2023J01829)
- License Information
-
More Information
Article History
Received: 11 July 2024
Revised: 30 October 2024
Accepted: 1 November 2024
First Online: 12 November 2024
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Patient-derived primary breast cancer cells (BC4#) used in this study were established and kindly provided by Dr. Xiaowei Dou, with approval from the Ethics Committee of the Affiliated Hospital of Guizhou Medical University (#2022-313). Informed consent was obtained from the patient before participating in the study [].
: During the preparation of this work the authors used CHATGPT3.5 in order to check grammar and polish the English language quality. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
